array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(14) "ELEKTA LIMITED"
["slug"]=>
string(23) "dbe4b-gb-elekta-limited"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/03cdfb0f-1bfc-426b-afae-aad1f451dee7"
["description"]=>
string(735) "At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more."
["address_street"]=>
string(11) "Linac House"
["address_place"]=>
string(7) "CRAWLEY"
["address_region"]=>
NULL
["founding_date"]=>
string(10) "1996-09-02"
["website_domain"]=>
string(10) "elekta.com"
["website_url"]=>
string(22) "https://www.elekta.com"
["industry_codes"]=>
array(1) {
[0]=>
string(46) "Surgical and Medical Instruments and Apparatus"
}
["employee_count"]=>
int(820)
["article_count"]=>
int(550)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(37) "Elekta rises after buy stamp from SEB"
["snippet_en"]=>
string(235) "SEB anticipates a buy position in the radiation therapy company Elekta after the recent price decline and raises its recommendation. The stock rose marginally in Tuesday's opening trade on an otherwise falling Stockholm stock exchange."
["url"]=>
string(63) "https://www.di.se/live/elekta-stiger-efter-kopstampel-fran-seb/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/8f55c6b9-724e-4c8e-8f18-55ed1f6b6fcd"
["source"]=>
string(5) "di.se"
["publication_date"]=>
string(10) "2023-09-26"
["categories"]=>
array(3) {
[0]=>
string(12) "Stock Market"
[1]=>
string(12) "Going Public"
[2]=>
string(21) "Competitive Behaviour"
}
}
[1]=>
array(7) {
["title_en"]=>
string(14) "Today's shrimp"
["snippet_en"]=>
string(137) "SEB raises Elekta to buy and raises its target price for Swedbank. Here is a summary of Tuesday's recommendation and target rate changes."
["url"]=>
string(69) "https://www.di.se/live/seb-hojer-elekta-till-kop-har-ar-dagens-rekar/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/beb29ae3-3d0d-485d-8e65-4d326e6095b6"
["source"]=>
string(5) "di.se"
["publication_date"]=>
string(10) "2023-09-26"
["categories"]=>
array(3) {
[0]=>
string(12) "Stock Market"
[1]=>
string(11) "Acquisition"
[2]=>
string(13) "Credit Rating"
}
}
[2]=>
array(7) {
["title_en"]=>
string(57) "The stock exchange's most shorted shares - the whole list"
["snippet_en"]=>
string(198) "The Stockholm Stock Exchange's most traded share still belongs to the real estate company SBB. The housing developer JM and the radiation therapy company Elekta shadow behind. Here is the full list."
["url"]=>
string(90) "https://www.privataaffarer.se/placeringar/aktier/borsens-mest-blankade-aktier-hela-listan/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/9f6c21ae-f916-4cc8-be8e-70c8cd566aee"
["source"]=>
string(17) "privataaffarer.se"
["publication_date"]=>
string(10) "2023-09-15"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(12) "Going Public"
}
}
[3]=>
array(7) {
["title_en"]=>
string(38) "Elekta shatters expectations – again"
["snippet_en"]=>
string(115) "Elekta's report exceeded expectations. The profit increases sharply and the stock continues to be considered a buy."
["url"]=>
string(61) "https://www.di.se/analys/elekta-krossar-forvantningarna-igen/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/2a6e4b50-3a64-4eed-adbb-6b62faefe5f9"
["source"]=>
string(5) "di.se"
["publication_date"]=>
string(10) "2023-08-24"
["categories"]=>
array(3) {
[0]=>
string(12) "Stock Market"
[1]=>
string(31) "Financial Update/Profit Warning"
[2]=>
string(24) "Quarterly/Annual Figures"
}
}
[4]=>
array(7) {
["title_en"]=>
string(41) "Wide rise on the Stockholm Stock Exchange"
["snippet_en"]=>
string(166) "The Stockholm Stock Exchange starts up on Thursday with many quarterly reports. Among other things, Elekta is dropping somewhat, while Surgical Science is plummeting."
["url"]=>
string(95) "https://www.privataaffarer.se/alla-nyheter/borstelegram/bred-uppgang-pa-stockholmsborsen-bfFhi/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/76d656fd-9ec9-44c4-b679-5db6589055fc"
["source"]=>
string(17) "privataaffarer.se"
["publication_date"]=>
string(10) "2023-08-24"
["categories"]=>
array(3) {
[0]=>
string(12) "Stock Market"
[1]=>
string(15) "Insider Trading"
[2]=>
string(12) "Going Public"
}
}
[5]=>
array(7) {
["title_en"]=>
string(40) "Elekta falls after 'talking to analysts'"
["snippet_en"]=>
string(273) "The radiation therapy company Elekta has turned sharply down on the stock market around lunchtime. The stock retreats 6.4% without any company-specific news coming out. However, the company has spoken to an analyst, says IR manager Cecilia Ketels to the Direkt news agency."
["url"]=>
string(85) "https://www.affarsvarlden.se/artikel/elekta-faller-efter-att-ha-pratat-med-analytiker"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/5f29f410-2296-47ce-a1ed-4596194cce13"
["source"]=>
string(16) "affarsvarlden.se"
["publication_date"]=>
string(10) "2023-04-17"
["categories"]=>
array(1) {
[0]=>
string(12) "Stock Market"
}
}
[6]=>
array(7) {
["title_en"]=>
string(54) "Elekta down and SAS up on the Stockholm Stock Exchange"
["snippet_en"]=>
string(162) "A positive start on the Stockholm Stock Exchange turned during the day into a slightly sloping trend, which ended in the red, with the broad index OMXSPI down 0.2"
["url"]=>
string(79) "https://www.dagensps.se/bors-finans/elekta-ned-och-sas-upp-pa-stockholmsborsen/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/acaf8882-d79a-4de5-ab45-72df17732386"
["source"]=>
string(11) "dagensps.se"
["publication_date"]=>
string(10) "2023-04-17"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(12) "Going Public"
}
}
[7]=>
array(7) {
["title_en"]=>
string(60) "Elekta top: No new information - analyst: More positive tone"
["snippet_en"]=>
string(351) "On the last day before radiation therapy company Elekta enters a quiet period ahead of the report for the third quarter, the stock on the Stockholm Stock Exchange is soaring. As usual, the company's IR department has informed analysts right up to the last minute. "We have not given any new information," says the company's head of IR, Cecilia Ketels."
["url"]=>
string(89) "https://www.di.se/nyheter/elekta-toppen-ingen-ny-information-analytikern-mer-positiv-ton/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/cfadb111-2ed1-477b-a05a-f604720c0bbc"
["source"]=>
string(5) "di.se"
["publication_date"]=>
string(10) "2023-01-24"
["categories"]=>
array(1) {
[0]=>
string(12) "Stock Market"
}
}
[8]=>
array(7) {
["title_en"]=>
string(62) "Elekta and Philips deepen strategic partnership in precise ..."
["snippet_en"]=>
string(251) "STOCKHOLM and AMSTERDAM, June7, 2021– Elekta( EKTA-B.ST) and Royal Philips( NYSE: PHG, AEX: PHIA) today signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology"
["url"]=>
string(145) "https://www.elekta.com/pressreleases/A1F782295C663B6C/elekta-and-philips-deepen-strategic-partnership-in-precise-and-individualized-oncology-care"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/f9ab6487-287b-4668-a7ac-054b6f855207"
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2021-06-07"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(13) "Collaboration"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(35)
}
[1]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(25)
}
[2]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(23)
}
[3]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(19)
}
[4]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(16)
}
[5]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(16)
}
[6]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(15)
}
[7]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(14)
}
[8]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(11)
}
[9]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(11)
}
[10]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(11)
}
[11]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(9)
}
[12]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(8)
}
[13]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(7)
}
[14]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(6)
}
[15]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(6)
}
[16]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(6)
}
[17]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(6)
}
[18]=>
array(2) {
["name"]=>
string(25) "Leadership and Governance"
["count"]=>
int(5)
}
[19]=>
array(2) {
["name"]=>
string(10) "Executives"
["count"]=>
int(5)
}
[20]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(5)
}
[21]=>
array(2) {
["name"]=>
string(21) "Shareholders Feedback"
["count"]=>
int(4)
}
[22]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(4)
}
[23]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(4)
}
[24]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(4)
}
[25]=>
array(2) {
["name"]=>
string(17) "Energy Management"
["count"]=>
int(3)
}
[26]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(3)
}
[27]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(3)
}
[28]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(2)
}
[29]=>
array(2) {
["name"]=>
string(21) "Intellectual Property"
["count"]=>
int(2)
}
}
}
dbe4b-gb-elekta-limited
ELEKTA LIMITED
Location
Founded
1996-09-02
Website
https://www.elekta.com
Articles
550 Articles
Category
Surgical and Medical Instruments and Apparatus
Description
At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more.
SEB anticipates a buy position in the radiation therapy company Elekta after the recent price decline and raises its recommendation. The stock rose marginally in Tuesday's opening trade on an otherwise falling Stockholm stock exchange.
The Stockholm Stock Exchange's most traded share still belongs to the real estate company SBB. The housing developer JM and the radiation therapy company Elekta shadow behind. Here is the full list.
The Stockholm Stock Exchange starts up on Thursday with many quarterly reports. Among other things, Elekta is dropping somewhat, while Surgical Science is plummeting.
The radiation therapy company Elekta has turned sharply down on the stock market around lunchtime. The stock retreats 6.4% without any company-specific news coming out. However, the company has spoken to an analyst, says IR manager Cecilia Ketels to the Direkt news agency.
A positive start on the Stockholm Stock Exchange turned during the day into a slightly sloping trend, which ended in the red, with the broad index OMXSPI down 0.2
On the last day before radiation therapy company Elekta enters a quiet period ahead of the report for the third quarter, the stock on the Stockholm Stock Exchange is soaring. As usual, the company's IR department has informed analysts right up to the last minute. "We have not given any new information," says the company's head of IR, Cecilia Ketels.
STOCKHOLM and AMSTERDAM, June7, 2021– Elekta( EKTA-B.ST) and Royal Philips( NYSE: PHG, AEX: PHIA) today signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
